We are live on ! Find out more
EWM

Essex Woodlands Management Portfolio holdings

AUM $254M
1-Year Est. Return 4.59%
This Fund
S&P 500
This Quarter Est. Return
+18.35%
1 Year Est. Return
+4.59%
3 Year Est. Return
+54.96%
5 Year Est. Return
+25.37%
10 Year Est. Return
+254.56%
AUM
$457M
AUM Growth
-$96.3M
Cap. Flow
-$181M
Cap. Flow %
-39.52%
Top 10 Hldgs %
100%
Holding
10
New
1
Increased
Reduced
1
Closed
1

Top Buys

Rank Stock Value
1
EYPT icon
EyePoint Inc
EYPT
+$9.73M

Sector Composition

Rank Sector Weight
1 Healthcare 97.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
AXGN icon
1
Axogen
AXGN
$2.61B
$135M 29.64%
3,711,111
RVNC
2
DELISTED
Revance Therapeutics, Inc.
RVNC
$118M 25.9%
3,842,047
CORI
3
DELISTED
Corium International, Inc.
CORI
$107M 23.48%
9,353,304
ABMD
4
DELISTED
Abiomed Inc
ABMD
$58.7M 12.85%
201,818
-445,000
-69% -$113M
MNOV icon
5
MediciNova
MNOV
$65M
$12M 2.62%
1,170,370
ELGX
6
DELISTED
Endologix Inc
ELGX
$11.6M 2.53%
125,747
EYPT icon
7
EyePoint Inc
EYPT
$1.13B
$10.5M 2.3%
+860,632
New +$9.73M
GYRE icon
8
Gyre Therapeutics
GYRE
$704M
$2.11M 0.46%
10,483
ACUR
9
DELISTED
Acura Pharmaceuticals
ACUR
$998K 0.22%
1,956,397
ENTL
10
DELISTED
Entellus Medical, Inc. Common Stock
ENTL
-3,231,656
Closed -$77.6M

Similar funds

Essex Woodlands Management's Q1 2018 Portfolio in Review

As of Q1 2018, Essex Woodlands Management held 10 positions worth $457M, down 17% from $553M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Essex Woodlands Management withdrew a net $181M in Q1 2018, closing 1 position and reducing 1 holding. Its most notable exit was Entellus Medical, Inc. Common Stock, an estimated $77.6M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, down from 98% a quarter earlier.

Against the trend, Essex Woodlands Management opened a new position in EyePoint Inc worth $10.5M.

  • Essex Woodlands Management's largest Q1 2018 buy was EyePoint Inc: 860,632 shares worth $10.5M.
  • Essex Woodlands Management's biggest Q1 2018 reduction was Abiomed Inc, cutting an estimated $113M.
  • Essex Woodlands Management fully exited Entellus Medical, Inc. Common Stock in Q1 2018, selling an estimated $77.6M.
  • Essex Woodlands Management's ten largest holdings make up 100% of its $457M portfolio in Q1 2018.
  • Essex Woodlands Management opened 1 new position and closed 1 in Q1 2018.
  • Essex Woodlands Management's portfolio value fell 17% quarter-over-quarter to $457M.

Based on Essex Woodlands Management's 13F filing for Q1 2018, filed 15 May 2018.